D.E. Shaw & Co’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.47M | Buy |
145,018
+28,050
| +24% | +$686K | ﹤0.01% | 2464 |
|
|
2025
Q4 | $2.65M | Sell |
116,968
-72,436
| -38% | -$1.58M | ﹤0.01% | 2822 |
|
|
2025
Q3 | $3.81M | Sell |
189,404
-25,684
| -12% | -$430K | ﹤0.01% | 2459 |
|
|
2025
Q2 | $3.07M | Sell |
215,088
-168,463
| -44% | -$1.97M | ﹤0.01% | 2411 |
|
|
2025
Q1 | $4.03M | Sell |
383,551
-277,088
| -42% | -$3.13M | ﹤0.01% | 2061 |
|
|
2024
Q4 | $8M | Sell |
660,639
-367,985
| -36% | -$4.82M | 0.01% | 1643 |
|
|
2024
Q3 | $15.1M | Sell |
1,028,624
-1,502,831
| -59% | -$20.9M | 0.01% | 1163 |
|
|
2024
Q2 | $36.5M | Sell |
2,531,455
-1,756,934
| -41% | -$28.1M | 0.03% | 573 |
|
|
2024
Q1 | $69.8M | Sell |
4,288,389
-166,587
| -4% | -$2.6M | 0.06% | 363 |
|
|
2023
Q4 | $66.4M | Sell |
4,454,976
-635,685
| -12% | -$7.2M | 0.06% | 387 |
|
|
2023
Q3 | $57.2M | Sell |
5,090,661
-4,423,987
| -46% | -$51.4M | 0.06% | 386 |
|
|
2023
Q2 | $95.7M | Buy |
9,514,648
+1,680,380
| +21% | +$15.6M | 0.1% | 237 |
|
|
2023
Q1 | $73.6M | Sell |
7,834,268
-577,953
| -7% | -$6.82M | 0.08% | 303 |
|
|
2022
Q4 | $103M | Buy |
8,412,221
+2,790,134
| +50% | +$34.8M | 0.11% | 196 |
|
|
2022
Q3 | $69.8M | Buy |
5,622,087
+3,152,960
| +128% | +$55.1M | 0.08% | 272 |
|
|
2022
Q2 | $48.5M | Sell |
2,469,127
-472,315
| -16% | -$11.2M | 0.06% | 413 |
|
|
2022
Q1 | $76.7M | Sell |
2,941,442
-967,969
| -25% | -$25.8M | 0.07% | 321 |
|
|
2021
Q4 | $111M | Buy |
3,909,411
+2,287,366
| +141% | +$71.1M | 0.09% | 238 |
|
|
2021
Q3 | $51.7M | Sell |
1,622,045
-943,974
| -37% | -$31.7M | 0.05% | 516 |
|
|
2021
Q2 | $89M | Buy |
2,566,019
+1,908,455
| +290% | +$62.9M | 0.08% | 306 |
|
|
2021
Q1 | $19.4M | Buy |
657,564
+285,551
| +77% | +$8.78M | 0.02% | 947 |
|
|
2020
Q4 | $11.4M | Sell |
372,013
-284,487
| -43% | -$8.68M | 0.01% | 1307 |
|
|
2020
Q3 | $18.3M | Sell |
656,500
-1,116,007
| -63% | -$28.3M | 0.02% | 882 |
|
|
2020
Q2 | $38M | Sell |
1,772,507
-1,406,462
| -44% | -$31.1M | 0.05% | 470 |
|
|
2020
Q1 | $71.2M | Buy |
3,178,969
+18,627
| +0.6% | +$510K | 0.11% | 205 |
|
|
2019
Q4 | $93.1M | Buy |
3,160,342
+1,674,553
| +113% | +$45.5M | 0.11% | 221 |
|
|
2019
Q3 | $39.5M | Buy |
1,485,789
+543,418
| +58% | +$16.3M | 0.05% | 464 |
|
|
2019
Q2 | $31.9M | Sell |
942,371
-169,907
| -15% | -$5.52M | 0.04% | 533 |
|
|
2019
Q1 | $35.7M | Sell |
1,112,278
-369,971
| -25% | -$11.4M | 0.05% | 482 |
|
|
2018
Q4 | $46.7M | Buy |
1,482,249
+475,755
| +47% | +$15.6M | 0.06% | 366 |
|
|
2018
Q3 | $35.1M | Buy |
+1,006,494
| New | +$35.4M | 0.04% | 528 |
|
Other funds holding ELAN
VPM
VCM
D.E. Shaw & Co's ELAN Position: Q1 2026 in Review
D.E. Shaw & Co increased its Elanco Animal Health (ELAN) stake by 24% in Q1 2026, buying an estimated $686K and bringing the position to 145,018 shares worth $3.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2464.
D.E. Shaw & Co first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $111M in Q4 2021. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.
- D.E. Shaw & Co held 145,018 shares of Elanco Animal Health worth $3.47M as of Q1 2026.
- D.E. Shaw & Co bought 28,050 Elanco Animal Health shares in Q1 2026, an estimated $686K.
- Elanco Animal Health made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2464 holding.
- D.E. Shaw & Co first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
- D.E. Shaw & Co's Elanco Animal Health position peaked at $111M in Q4 2021.
- 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.